Host and parasite responses in human diffuse cutaneous leishmaniasis caused by L. amazonensis.
Stephen M ChristensenAshton T BelewNajib M El-SayedWagner L TafuriFernando T SilveiraDavid M MosserPublished in: PLoS neglected tropical diseases (2019)
Diffuse cutaneous leishmaniasis (DCL) is a rare form of leishmaniasis where parasites grow uncontrolled in diffuse lesions across the skin. Meta-transcriptomic analysis of biopsies from DCL patients infected with Leishmania amazonensis demonstrated an infiltration of atypical B cells producing a surprising preponderance of the IgG4 isotype. DCL lesions contained minimal CD8+ T cell transcripts and no evidence of persistent TH2 responses. Whereas localized disease exhibited activated (so-called M1) macrophage presence, transcripts in DCL suggested a regulatory macrophage (R-Mϕ) phenotype with higher levels of ABCB5, DCSTAMP, SPP1, SLAMF9, PPARG, MMPs, and TM4SF19. The high levels of parasite transcripts in DCL and the remarkable uniformity among patients afforded a unique opportunity to study parasite gene expression in this disease. Patterns of parasite gene expression in DCL more closely resembled in vitro parasite growth in resting macrophages, in the absence of T cells. In contrast, parasite gene expression in LCL revealed 336 parasite genes that were differently upregulated, relative to DCL and in vitro macrophage growth, and these transcripts may represent transcripts that are produced by the parasite in response to host immune pressure.
Keyphrases
- plasmodium falciparum
- gene expression
- toxoplasma gondii
- trypanosoma cruzi
- life cycle
- dna methylation
- low grade
- adipose tissue
- end stage renal disease
- endothelial cells
- ejection fraction
- magnetic resonance
- magnetic resonance imaging
- chronic kidney disease
- genome wide
- peritoneal dialysis
- rna seq
- bioinformatics analysis